CRVS vs ZTS · $1.04B cap vs P/E 25, rev $2.47B
Corvus Pharmaceuticals Inc (CRVS) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Corvus Pharmaceuticals Inc (CRVS) is a biotechnology company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
CRVS does not have a complete income-statement cache yet.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
CRVS currently screens at market cap $1.04B. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the CRVS and ZTS stock pages for the full models.
Not investment advice.